Quality and authenticity of heterologous proteins synthesized in yeast

Current Opinion in Biotechnology

Volumn 7, Issue 5, 1996, Pages 525-530

  Eckart, Michael R ^a   Bussineau, Christopher M ^b  

^a BAYER CORPORATION   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

DNA SEQUENCE; ENDOMYCETALES; GENE MUTATION; INDUSTRY; NONHUMAN; PHARMACEUTICS; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE; SHORT SURVEY; YEAST;

PICHIA PASTORIS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES;

EID: 0030272217     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(96)80056-5     Document Type: Article

References (47)

1. Pichuantes S, Nguyen AT, Franzusoff A. Expression of heterologous gene products in yeast. Protein Engineering: Principles and Practice. Cleland JL, Craik CS. 1996;129-161 Wiley Liss, New York.
2. Romanos M. Advances in the use of Pichia pastoris for high-level gene expression. Curr Opin Biotechnol. 6:1995;527-533.
3. Faber KN, Harder W, Ab G, Veenhuis M. Review: methylotrophic yeasts as factories for the production of foreign proteins. Yeast. 11:1995;1331-1344.
4. Bussineau CM, Shuster JA. Genetic stability for protein expression systems in yeast. Dev Biol Stand. 83:1994;13-19.
5. Van den Hazel HB, Kielland-Brandt MC, Winther JR. Review: biosynthesis and function of yeast vacuolar proteases. of outstanding interest Yeast. 12:1996;1-16 An excellent review of vacuolar proteolysis and its impact on post-translational modification of gene products.
6. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature. 298:1982;347-350.
7. Cregg JM, Tschopp JF, Stillman C, Siegel R, Akong M, Craig WS, Buckholz RG, Madden KR, Kellaris PA, Davis GR, et al. High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. Bio-Technology. 5:1987;479-485.
8. Janowicz ZA, Melber K, Merckelbach A, Jacobs E, Harford N, Comberbach M, Hollenberg CP. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast Hansenula polymorpha. Yeast. 7:1991;413-420.
9. +ATPase b subunit. Proc Natl Acad Sci USA. 89:1992;2834-2838.
10. +-ATPase in yeast. J Biol Chem. 265:1990;4189-4192.
11. Hofman O, Mould R, Brittain T. Allosteric modulation of oxygen binding to the three human embryonic haemoglobins. Biochem J. 306:1995;367-370.
12. Evans GL, Ni B, Hrycyna CA, Chen D, Ambudkar SV, Pastan I, Germann UA, Gottesman MM. Heterologous expression systems for P-glycoprotein: E. coli, yeast and baculovirus. of special interest J Bioenerg Biomembr. 27:1995;43-52 A comparison of the expression in different hosts of a membrane glycoprotein.
13. Grisshammer R, Tate CG. Overexpression of integral membrane proteins for structural studies. of special interest Q Rev Biophys. 28:1995;315-422 A comprehensive review of the strategies and techniques for the expression of various membrane proteins in different hosts that may be generalizable to other protein classes.
14. +-ATPase in yeast endoplasmic reticulum. J Biol Chem. 267:1992;12341-12349.
15. Reutz S, Gros P. Functional expression of P-glycoprotein in secretory vesicles. J Biol Chem. 269:1994;12277-12284.
16. Sekler I, Kopito R, Casey JR. High level expression, partial purification, and functional reconstitution of the human AE1 anion exchanger in Saccharomyces cerevisiae. J Biol Chem. 270:1995;21028-21034.
17. ++ antagonist binding protein. J Biol Chem. 270:1995;7551-7557.
18. Mak P, Fuernkranz HA, Ge R, Karathanasis SK. Retinoid X receptor homodimers function as transcriptional activators in yeast. Gene. 145:1994;129-133.
19. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ Jr, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science. 272:1996;1489-1492.
20. +-ATPase was used to determine the roles of the eight cysteine residues in its structure and molecular mechanism.
21. 2s dopamine receptor in the yeast Saccharomyces cerevisiae and Schizosaccharomyces pombe: a comparative study. FEBS Lett. 344:1994;41-46.
22. 5A serotonin receptor in the methylotrophic yeast Pichia pastoris: pharmacological characterization and localization. FEBS Lett. 377:1996;451-456.
23. Schreuder MP, Mooren ATA, Toschka HY, Verrips CT, Klis FM. Immobilizing proteins on the surface of yeast cells. Trends Biotechnol. 14:1996;115-120.
24. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
25. Barr PJ, Steimer KS, Sabin EA, Parkes D, George-Nascimento C, Stephans JC, Powers MA, Gyenes A, Van Nest GA, Miller ET, Higgins KW, Luciw PA. Antigenicity and imunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. Vaccine. 5:1987;90-101.
26. Ecker DJ, Stadel JM, Butt TR, Marsh JA, Monia BP, Powers DA, Gorma JA, Clark PE, Warren F, Shatzman A, Crooke ST. Increasing gene expression in yeast by fusion to ubiquitin. J Biol Chem. 264:1989;7715-7719.
27. Sabin EA, Lee-Ng CT, Shuster J, Barr PJ. High-level expression and in vivo processing of chimeric ubiquitin fusion proteins in Saccharomyces cerevisiae. Bio-Technology. 7:1989;705-709.
28. Luo D, Mah N, Krantz M, Wilde K, Wishart D, Zhang Y, Jacobs F, Martin L. VI - linker - Vh orientation-dependent expression of single chain Fv containing an engineered disulfide-stabilized bond in the framework regions. J Biochem. 118:1995;825-831.
29. Ridder R, Schmitz R, Legay F, Gram H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Bio-Technology. 13:1995;255-260.
30. Crabe T, Weir AN, Walton EF, Brown ME, Sutton CW, Tretout N, Bonnerjea J, Lowe PA, Yarranton GT. The secretion of active recombinant human gastric lipase by Saccharomyces cerevisiae. Protein Expr Purif. 7:1996;229-236.
31. Rosenfeld SA, Ross OH, Hillman MC, Corman JI, Dowling RL. Production and purification of human fibroblast collagenase (MMP-1) expressed in the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 7:1996;423-430.
32. Petersen LC, Bjorn SE, Olsen OH, Nordfang O, Norris F, Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor. Eur J Biochem. 235:1996;310-316.
33. Wernette-Hammond ME, Shyamala V, Siani MA, Gallegos CA, Feucht PH, Abbott J, Reza Lapointe G, Moghadam M, Khoja H, Zakel J, Tekamp-Olson P. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. J Biol Chem. 271:1996;8228-8235.
34. Zhu A, Monahan C, Zhang Z, Hurst R, Leng L, Goldstein J. High-level expression and purification of coffee bean galactosidase produced in the yeast Pichia pastoris. Arch Biochem Biophys. 324:1995;65-70.
35. Vozza LA, Wittwer L, Higgins DR, Purcell TJ, Bergseid M, Collins-Racie LA, LaVallie ER, Hoeffler JP. Production of a recombinant bovine enterokinase catalytic subunit in methylotrophic yeast Pichia pastoris. Bio-Technology. 14:1996;77-81.
36. Lipps G, Fullkrug R, Beck E. Cathepsin B of Schistosoma mansoni. J Biol Chem. 271:1996;1717-1725.
37. Kjeldsen T, Brandt J, Andersen AS, Egel-Mitani M, Hach M, Petterson AF, Vad K. A removable spacer peptide in an α-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae. of outstanding interest Gene. 170:1996;107-112 An example of a Kex2 protease processing problem and its effects on concomitant secretion wherein efficiency of expression of the correct insulin precursor protein is increased significantly when the gene product contains a spacer between the Kex2p cleavage site and the mature amino terminus.
38. Parekh R, Forrester K, Wittrup D. Multicopy overexpression of bovine pancreatic trypsin inhibitor saturates the protein folding and secretory capacity of Saccharomyces cerevisiae. of special interest Protein Expr Purif. 6:1995;537-545 Using an expression system for BPTI in S. cerevisiae, the authors showed that overexpressed protein accumulates intracellularly in an unfolded form due to the saturation of the folding capacity of the secretory apparatus. This study is a good beginning in the efforts to understand the mechanisms underlying protein folding limitations in the lumen of the endoplasmic reticulum.
39. Robinson AS, Wittrup D. Constitutive overexpression of secreted heterologous proteins decreases extractable BiP and protein disulfide isomerase levels in Saccharomyces cerevisiae. Biotechnol Prog. 11:1995;171-177.
40. Meynial-Salles I, Combes D. In vitro glycosylation of proteins: an enzymatic approach. of outstanding interest J Biotechnol. 46:1996;1-14 A good review of the specific enzymes involved in the glycosylation pathway and the composition, structure and biosynthesis of glycoproteins in various hosts.
41. Wang C, Eufemi M, Turano C, Giartosio A. Influence of carbohydrate moiety on the stability of glycoproteins. of outstanding interest Biochemistry. 35:1996;7299-7307 This key paper describes the importance of glycosylation for the thermal stability of glycoproteins. Five models were selected from different sources and purified to homogeneity, then deglycosylated with endoglycosidases and exoglycosidases in native conditions. Thermal stability and conformational change were determined.
42. Masure S, Paemen L, Proost P, Van Damme J, Opdenakker. Expression of a human mutant monocyte chemotactic protein 3 in Pichia pastoris and characterization as an MCP3 receptor antagonist. J Interferon Cytokine Res. 15:1995;955-963.
43. T synthesis, transport to the cell surface, cleavage processing, and enzymatic activity. Results from the experiments indicate that eukaryotic protein trafficking and post-translational modification may not be equivalent in yeast and higher eukaryotes.
44. Stratton-Thomas J, Min HY, Kaufman SE, Chiu CY, Mullenbach GT, Rosenberg S. Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain. Protein Eng. 8:1995;463-470.
45. O'Neill GF. Glycotechnology: an emerging field in biochemistry, cell biology, and pharmaceutical development. Am Biotechnol. 12:1994;12-14.
46. Garcia R, Rodriguez R, Montesino R, Besada V, Gonzalez M, Cremata JA. Concavalin A- and wheat germ agglutinin-conjugated lectins as a tool for the identification of multiple N-glycosylation sites in heterologous protein expressed in yeast. of special interest Anal Biochem. 231:1995;342-348 A simple methodology that allows the identification of glycosylation sites was applied to a model glycoprotein, α-amylase from Bacillus licheniformis, which is unglycosylated in its native host but appears highly glycosylated when expressed in Pichia pastoris.
47. Harmon BJ, Gu X, Wang IC. Rapid monitoring of site specific glycosylation microheterogeneity of recombinant human interferon-γ Anal Chem. 68:1996;1465-1473.